These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both. Gereige RS; Barrios NJ P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200 [TBL] [Abstract][Full Text] [Related]
3. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura. Erduran E; Aslan Y; Gedik Y; Orhan F Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur. Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309 [TBL] [Abstract][Full Text] [Related]
5. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy. Duru F; Fisgin T; Yarali N; Kara A Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587 [TBL] [Abstract][Full Text] [Related]
6. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura. Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607 [TBL] [Abstract][Full Text] [Related]
7. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000]. Kjaersgaard M; Edslev PW; Rosthøj S Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M; Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672 [TBL] [Abstract][Full Text] [Related]
10. Treatment of acute idiopathic thrombocytopenic purpura in children. A retrospective evaluation of 120 cases. Baronci C; Petrone A; Miano C; Lombardi A; Caniglia M; Russo LA; Luciani M; Pinto RM; Rana I; Caruso R; De Rossi G Ann Ist Super Sanita; 1998; 34(4):457-61. PubMed ID: 10234876 [TBL] [Abstract][Full Text] [Related]
11. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS). Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971 [TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura. Fujisawa K; Iyori H; Ohkawa H; Konishi S; Bessho F; Shirahata A; Miyazaki S; Akatsuka J; Int J Hematol; 2000 Oct; 72(3):376-83. PubMed ID: 11185998 [TBL] [Abstract][Full Text] [Related]
13. Idiopathic thrombocytopenic purpura: a 15-year natural history study at the Children's Hospital Rijeka, Croatia. Roganovic J; Letica-Crepulja M Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):662-4. PubMed ID: 16933251 [TBL] [Abstract][Full Text] [Related]
14. [Randomized comparison of intravenous immunoglobulin and methylprednisolone pulse therapy in children with newly diagnosed idiopathic thrombocytic purpura. The Danish ITP Study Group]. Rosthøj S; Nielsen SM; Pedersen FK Ugeskr Laeger; 1998 Mar; 160(11):1640-4. PubMed ID: 9522658 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials. Qin YH; Zhou TB; Su LN; Lei FY; Zhao YJ; Huang WF Blood Coagul Fibrinolysis; 2010 Dec; 21(8):713-21. PubMed ID: 20962624 [TBL] [Abstract][Full Text] [Related]
17. [Use of corticosteroids and immunoglobulins in acute and chronic immune thrombocytopenia in childhood. A clinically oriented treatment concept]. Höcker-Schulz S; Elstner T; Pawlosky J; Gadner H Klin Padiatr; 1997; 209(1):30-5. PubMed ID: 9121075 [TBL] [Abstract][Full Text] [Related]
18. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Khellaf M; Michel M; Schaeffer A; Bierling P; Godeau B Haematologica; 2005 Jun; 90(6):829-32. PubMed ID: 15951296 [TBL] [Abstract][Full Text] [Related]
19. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients. Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR; Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of immune thrombocytopenic purpura in Pediatrics. Therapeutic efficacy of a regional intravenous immunoglobulin G]. Buteler C; Colombo H; Gabosi G; Manfredi MJ; Montero S; Pasquali MA; Rougier C; Sisti AM Medicina (B Aires); 2001; 61(5 Pt 1):522-8. PubMed ID: 11721317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]